William J. Martin, PhD

Working at the intersections of science and business, I am committed to neuroscience, advancing foundational and applied research, AI x Bio, science policy and society, and biomedical workforce development.

Former SVP/Global Head of Neuroscience R&D at Johnson & Johnson
Cofounder Blackthorn Therapeutics, acquired by Neumora (NASDAQ: NMRA)

Writing

The Business of Being a ScientistApril 2026
Applying Proteomics and Machine Learning to Accelerate Alzheimer's BreakthroughsJuly 2025
How to Catalyze Growth in Neuropsychiatric R&DOctober 2023

Workshops

Exploring the Bidirectional Relationship Between Artificial Intelligence and Neuroscience: Proceedings of a WorkshopNational Academies · 2024
Advances in Therapeutics Development for Parkinson's DiseaseNINDS · 2024

Talks

The Promise of Precision NeuroscienceStanford University · September 2025
Redefining Diagnosis & Treatment of Brain Diseases in the 21st CenturyBrown University · May 2025
The Map Is Not the Territory: Redefining the Diagnosis and Treatment of Neuropsychiatric ConditionsGoldLab Symposium · May 2023

Leadership & Service

CouncilorSociety for Neuroscience (SfN)
Neuroscience Section RepresentativeAmerican Association for the Advancement of Science (AAAS)
Advisory Council MemberCarney Institute for Brain Science, Brown University
Advisory Board MemberLife Science & Management Program (LSM), University of Pennsylvania
Previous Board MemberAlliance for AI in Healthcare (AAIH)